X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11343) 11343
Publication (1153) 1153
Book Review (175) 175
Book Chapter (98) 98
Conference Proceeding (28) 28
Dissertation (26) 26
Reference (6) 6
Book / eBook (3) 3
Magazine Article (2) 2
Data Set (1) 1
Newspaper Article (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6815) 6815
glucagon-like peptide-1 (6812) 6812
humans (6100) 6100
animals (5038) 5038
male (4182) 4182
endocrinology & metabolism (3861) 3861
glucose (2624) 2624
diabetes (2622) 2622
glucagon (2538) 2538
type 2 diabetes (2449) 2449
female (2377) 2377
insulin (2373) 2373
glp-1 (2314) 2314
glucagon-like peptide 1 (2284) 2284
diabetes mellitus, type 2 - drug therapy (2156) 2156
rats (2090) 2090
mice (1960) 1960
peptides (1700) 1700
obesity (1601) 1601
hypoglycemic agents - therapeutic use (1543) 1543
middle aged (1516) 1516
blood glucose - metabolism (1483) 1483
adult (1472) 1472
pharmacology & pharmacy (1471) 1471
glucagon-like peptide-1 receptor (1435) 1435
glucagon-like peptide 1 - metabolism (1357) 1357
insulin - metabolism (1355) 1355
secretion (1294) 1294
liraglutide (1219) 1219
insulin - blood (1146) 1146
diabetes mellitus (1085) 1085
physiological aspects (1083) 1083
insulin secretion (1074) 1074
dextrose (1073) 1073
research (1028) 1028
glycemic control (1025) 1025
analysis (1004) 1004
glucagon-like peptide 1 - blood (987) 987
physiology (953) 953
biochemistry & molecular biology (941) 941
exenatide (941) 941
insulin resistance (937) 937
hypoglycemic agents - pharmacology (916) 916
digestive, oral, and skin physiology (906) 906
food-intake (885) 885
peptides - pharmacology (866) 866
diabetes mellitus, type 2 - metabolism (851) 851
aged (837) 837
glucagon-like peptide 1 - analogs & derivatives (825) 825
internal medicine (820) 820
medicine & public health (814) 814
endocrine system (805) 805
diabetes mellitus, type 2 - blood (800) 800
insulin-secretion (795) 795
metabolism (792) 792
glucagon-like peptide 1 - pharmacology (789) 789
health aspects (788) 788
expression (763) 763
glucose metabolism (763) 763
blood glucose - drug effects (758) 758
rodents (749) 749
beta-cell function (747) 747
exendin-4 (747) 747
type-2 diabetes-mellitus (741) 741
abridged index medicus (738) 738
incretin (723) 723
gastric-inhibitory polypeptide (719) 719
care and treatment (703) 703
receptor (702) 702
treatment outcome (702) 702
hormones, hormone substitutes, and hormone antagonists (686) 686
mice, inbred c57bl (679) 679
article (665) 665
glucose - metabolism (649) 649
hyperglycemia (649) 649
rats, sprague-dawley (642) 642
glucagon-like peptide 1 - therapeutic use (633) 633
nutrition & dietetics (632) 632
hormones (627) 627
hypoglycemic agents - administration & dosage (626) 626
glucose tolerance test (620) 620
venoms - pharmacology (619) 619
peptide fragments - pharmacology (617) 617
receptors, glucagon - agonists (616) 616
receptors, glucagon - metabolism (612) 612
body weight (603) 603
risk factors (603) 603
medicine, research & experimental (600) 600
metformin (568) 568
insulin-secreting cells - metabolism (564) 564
hypoglycemic agents (554) 554
rats, wistar (551) 551
double-blind (548) 548
insulin-resistance (547) 547
neurosciences (546) 546
surgery (542) 542
dipeptidyl-peptidase iv inhibitors - therapeutic use (538) 538
drug therapy (528) 528
glucagon-like peptide-1 receptor - agonists (525) 525
cell biology (518) 518
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11104) 11104
German (63) 63
Japanese (55) 55
Chinese (49) 49
Spanish (39) 39
French (37) 37
Korean (23) 23
Italian (13) 13
Russian (7) 7
Czech (4) 4
Danish (4) 4
Polish (4) 4
Hungarian (3) 3
Turkish (3) 3
Croatian (1) 1
Dutch (1) 1
Portuguese (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiovascular research, ISSN 0008-6363, 12/2016, Volume 112, Issue 3, pp. 669 - 676
Aims Although the nature of the humoral factor which mediates cardioprotection established by remote ischaemic conditioning (RIc) remains unknown,... 
Myocardial infarction | Parasympathetic | Glucagon-like peptide-1 | Cardioprotection | Reperfusion | Remote ischaemic conditioning | Myocardial ischaemia | Vagus nerve | INJURY SALVAGE KINASE | VAGUS | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTECTION | REPERFUSION INJURY | EXENATIDE | RECEPTOR | SIGNAL-TRANSDUCTION | HEART | ELEVATION MYOCARDIAL-INFARCTION | Phosphorylation | Receptor, Muscarinic M3 - drug effects | Vagus Nerve - drug effects | Male | Peptide Fragments - pharmacology | Exenatide | Ischemic Preconditioning - methods | Glucagon-Like Peptide-1 Receptor - metabolism | Myocardial Reperfusion Injury - pathology | Ligation | Muscarinic Antagonists - pharmacology | Glucagon-Like Peptide-1 Receptor - drug effects | Myocardial Infarction - pathology | Myocardium - metabolism | Myocardial Infarction - physiopathology | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | STAT3 Transcription Factor - metabolism | Disease Models, Animal | Glucagon-Like Peptide 1 - metabolism | Signal Transduction | Receptor, Muscarinic M3 - metabolism | Myocardium - pathology | Vagus Nerve - surgery | Myocardial Infarction - metabolism | Rats, Sprague-Dawley | Vagotomy | Myocardial Reperfusion Injury - physiopathology | Hormone Antagonists - pharmacology | Peptides - pharmacology | Vagus Nerve - physiopathology | Myocardial Reperfusion Injury - metabolism | Animals | Myocardial Infarction - prevention & control | Venoms - pharmacology | Glucagon-Like Peptide 1 - antagonists & inhibitors | Femoral Artery - surgery | Myocardial Reperfusion Injury - prevention & control | Original
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 09/2015, Volume 58, Issue 18, pp. 7370 - 7380
Journal Article
Journal Article
DIABETES OBESITY & METABOLISM, ISSN 1462-8902, 11/2014, Volume 16, Issue 11, pp. 1155 - 1164
Aims: To evaluate the performances of commercially available alucagon-like peptide-1 (GLP-1) assays and the implications for clinical studies. Methods: Known... 
PIGS | GASTRIC BYPASS | METABOLIC SURGERY | glucagon-like peptide-1 | precision | TISSUE | HUMANS | cross-reactivity | INCRETIN HORMONES | radioimmunoassay | INHIBITION | enzyme-linked immunosorbent assay | ENDOCRINOLOGY & METABOLISM | specificity | sensitivity | GLUCOSE-TOLERANCE
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2015, Volume 58, Issue 3, pp. 1020 - 1037
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e50117
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with type 2 diabetes mellitus (T2DM) because they concomitantly target... 
CONTROLLED-TRIAL | MAGNETIC-RESONANCE-SPECTROSCOPY | PLASMA ADIPONECTIN | HEPATIC INSULIN-RESISTANCE | MULTIDISCIPLINARY SCIENCES | CARDIOVASCULAR-DISEASE | INCREASED PREVALENCE | NONALCOHOLIC STEATOHEPATITIS | OPEN-LABEL | TRIGLYCERIDE CONTENT | ADIPOSE-TISSUE | Body Weight | Prospective Studies | Obesity - drug therapy | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - metabolism | Weight Loss - drug effects | Liver - drug effects | Glucagon-Like Peptide 1 - agonists | Adult | Female | Body Mass Index | Hypoglycemic Agents - therapeutic use | Adiposity - drug effects | Fatty Liver - metabolism | Glucagon-Like Peptide 1 - analogs & derivatives | Liver - metabolism | Fatty Liver - drug therapy | Obesity - metabolism | Blood Glucose - drug effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Liraglutide | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Adipose tissues | Type 2 diabetes | Obesity | Medical research | Care and treatment | Liver diseases | Glucagon | Body weight | Physiological aspects | Glycosylated hemoglobin | Medicine, Experimental | Nuclear magnetic resonance spectroscopy | Correlation | Adipose tissue | Liver | Body weight loss | Body composition | Magnetic resonance spectroscopy | Proton magnetic resonance | Ultrasonic imaging | Fatty liver | Rodents | Spectrum analysis | Measurement techniques | Aging | Hemoglobin | Pretreatment | Lipid metabolism | Glucagon-like peptide 1 | Chronic illnesses | Spectroscopy | Diabetes mellitus | Metabolism | Patients | Steatosis | Medicine | Weight control | Magnetic resonance imaging | Body mass | Biopsy | Weight reduction | Biomarkers | Insulin resistance | Resonance | Metformin | Diabetes | Endocrinology
Journal Article